Lukas Biomedical Inc. (6814.TWO) Stock
—
Valuation
Financials & Margins
About Lukas Biomedical Inc.
—
Lukas Biomedical Inc. is led by CEO Chaoan Liu, employs 87 people, headquartered in New Taipei, TW, publicly traded since 2020.
Lukas Biomedical Inc. (6814.TWO) stock trades at $17.60 with a market capitalization of $774.67M. The stock is valued at price-to-book of 4.05, price-to-sales of 4.56. Over the past 52 weeks the stock has ranged between $16.85 and $32.50, and currently trades 45.8% below its 52-week high.
On profitability, Lukas Biomedical Inc. generates a return on equity (ROE) of -38.79% (negative, reflecting a net loss), an operating margin of -60.04%, a net profit margin of -54.14%.
Official website: www.lukas-biomedical.com
Lukas Biomedical Inc. (6814.TWO) — frequently asked questions
What is Lukas Biomedical Inc. (6814.TWO) stock price today?
Lukas Biomedical Inc. (6814.TWO) is currently trading at $17.60, down 4.35% today.
What is 6814.TWO return on equity (ROE)?
Lukas Biomedical Inc.'s return on equity (ROE) is -38.79%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Lukas Biomedical Inc.'s market cap?
Lukas Biomedical Inc. has a market capitalization of $774.67M.
Does 6814.TWO pay a dividend?
Lukas Biomedical Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6814.TWO carry?
Lukas Biomedical Inc. has a debt-to-equity ratio of 1.30. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6814.TWO's profit margin?
Lukas Biomedical Inc. reports a net profit margin of -54.14% — the share of revenue left after every cost, including tax and interest.
What sector is 6814.TWO in?
Lukas Biomedical Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6814.TWO listed on?
Lukas Biomedical Inc. trades on TWO under the ticker 6814.TWO.
What is 6814.TWO's 52-week range?
Over the last year Lukas Biomedical Inc. has traded between $16.85 and $32.50.
Related — Stocks
Popular Stocks
Screens 6814.TWO currently matches
On the figures above, Lukas Biomedical Inc. passes the filters for 5 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.